🇺🇸 cabozantinib and nivolumab in United States

cabozantinib and nivolumab (cabozantinib and nivolumab) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

cabozantinib and nivolumab in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is cabozantinib and nivolumab approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for cabozantinib and nivolumab in United States?

Centre Francois Baclesse is the originator. The local marketing authorisation holder may differ — check the official source linked above.